Chinese english Germany Japanese Korea

Pasireotide Acetate

Pasireotide Acetate Struktur
396091-76-2
CAS-Nr.
396091-76-2
Englisch Name:
Pasireotide Acetate
Synonyma:
Pasireotide Acetate;Pasireotide Acetate(acetate);Somatostatin Receptor,sst3,Inhibitor,SOM230,SOM 230,Pasireotide,proapoptotic,sst1,antiproliferative,inhibit,somatostatin,SSTRs,sst4,SOM-230,SSTR,sst5,antisecretory,Pasireotide Acetate,sst2
CBNumber:
CB43379918
Summenformel:
C60H70N10O11
Molgewicht:
1107.28
MOL-Datei:
396091-76-2.mol
Request For Quotation

Pasireotide Acetate Eigenschaften

storage temp. 
Store at -20°C, protect from light, stored under nitrogen
Löslichkeit
DMSO : 100 mg/mL (90.31 mM; Need ultrasonic)
Aggregatzustand
Solid
Farbe
White to off-white

Sicherheit

Pasireotide Acetate Chemische Eigenschaften,Einsatz,Produktion Methoden

Pasireotide Acetate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Pasireotide Acetate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chengdu Youngshe Chemical Co., Ltd. 		+8618108235634
 Cecilia@youngshechem.com China 2345 58
Chengdu Youngshe Chemical Co., Ltd. +86-17380623303 +86-17380623303
 Caroline@youngshechem.com China 4903 58
Hangzhou Peptidego Biotech Co.,Ltd. 0571-87213919
eric@peptidego.com China 6526 58
Shanghai Luofa Biochemical Technology Co., Ltd. 021-51111890 15317326293
 sales@molnova.com China 4196 58
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 23963 58
Hangzhou Sinoda Pharmaceutical Technology Co. LTD 0571-87213919 17306812703
 3007955328@qq.com China 6213 58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd 021-59167510 18117107507
 vip@med-life.cn China 5012 58
  • Pasireotide Acetate
  • Pasireotide Acetate(acetate)
  • Somatostatin Receptor,sst3,Inhibitor,SOM230,SOM 230,Pasireotide,proapoptotic,sst1,antiproliferative,inhibit,somatostatin,SSTRs,sst4,SOM-230,SSTR,sst5,antisecretory,Pasireotide Acetate,sst2
  • 396091-76-2
Copyright 2019 © ChemicalBook. All rights reserved